InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
1
T+90 hit rate
67%
T+90 mean return
-14.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Thorell Marella, Directeur Comptable. Director active across 3 companies, notably Centessa Pharmaceuticals plc. Aggregated, 10 reports have been recorded. Split: 2 buys · 1 sell. Total volume traded: €37k. History available since 2 June 2021. The latest transaction was disclosed on 8 May 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
6,500 sharesCommon StockSEC:0001694665-23-000175:0
12,500 sharesCommon StockSEC:0001694665-23-000167:0
6,500 sharesCommon StockSEC:0001694665-23-000133:0
38,531 shares@ US$0.1255100.0% of flowCommon StockSEC:0001694665-23-000052:0
130,000 sharesCommon StockSEC:0001694665-23-000044:0
28,517 shares0Common StockSEC:0001824293-22-000082:0
38,023 shares0Common StockSEC:0001824293-22-000061:0
52,101 shares0Ordinary SharesSEC:0000899243-22-011946:0
1,000 shares@ US$20.000.0003% mcap50.0% of flowOrdinary SharesSEC:0000899243-21-022065:0
Ideal exit: 27 Feb 2022 (T+270)
1,000 shares@ US$20.0050.0% of flowOrdinary SharesSEC:0000899243-21-022065
Ideal exit: 27 Feb 2022 (T+270)
10 of 10 declarations
About Thorell Marella
Marella Thorell is the Chief Accounting Officer at Centessa Pharmaceuticals plc. She is responsible for managing the company's accounting operations and financial compliance. Her expertise in accounting is essential for ensuring transparency and reliability in financial reporting.
